公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2006 | Determinants of the differences in LDL-cholesterol after initiation of statin treatment | Kin-Wei Chan | Annals of Pharmacotherapy | 8 | 7 | |
2013 | Development and Validation of a Pharmacy-Based Comorbidity Measure in a Population-Based Automated Health Care Database | Dong, Yaa-Hui; CHIA-HSUIN CHANG ; Shau, Wen-Yi; Kuo, Raymond N.; Lai, Mei-Shu; KIN-WEI CHAN | Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy | 26 | 25 | |
2017 | Drug list compilation for pharmacoepidemiology studies using available public resource in Taiwan | Lin H.-M.; Juan Y.-C.; Chen C.-D.; KIN-WEI CHAN | Taiwan Journal of Public Health | 1 | 0 | |
2013 | Drug safety data mining with a tree-based scan statistic | Kin-Wei Chan | Pharmacoepidemiology and Drug Safety | 64 | 60 | |
2009 | Early adverse drug event signal detection within population-based health networks using sequential methods: Key methodologic considerations | Kin-Wei Chan | Pharmacoepidemiology and Drug Safety | 34 | 23 | |
2007 | Early detection of adverse drug events within population-based health networks: Application of sequential testing methods | Kin-Wei Chan | Pharmacoepidemiology and Drug Safety | 99 | 85 | |
1997 | Effectiveness of low-dose ASA in prevention of secondary ischemic stroke, the asa study group in Taiwan | Lee T.-K.; KIN-WEI CHAN ; ZEI-SHUNG HUANG ; Ng S.-K.; Lin R.-T.; Po H.L.; Yuan R.-Y.; Lai M.-L.; Chang T.-W.; Yan S.-H.; Deng J.-C.; Liu L.-H.; Lee K.-Y.; Lie S.-K.; Sung S.-M.; Hu H.-H. | Thrombosis Research | 13 | 15 | |
2015 | Effects of atorvastatin and rosuvastatin on renal function in patients with type 2 diabetes mellitus | CHAO LUN LAI ; Chou H.-W.; KIN-WEI CHAN ; Lai M.-S. | American Journal of Cardiology | 8 | 7 | |
2004 | Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study | Kin-Wei Chan | Current Therapeutic Research - Clinical and Experimental | 1 | 1 | |
2000 | Effects of statins [6] (multiple letters) | Kin-Wei Chan | Lancet | | | |
2015 | Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus | HUEY-LING CHEN ; CHIEN-NAN LEE ; Chang C.-H.; YEN-HSUAN NI ; MING-KWANG SHYU ; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; DING-SHINN CHEN ; KIN-WEI CHAN ; MEI-HWEI CHANG ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; JIA-FENG WU ; HONG-YUAN HSU ; CHUN-JEN LIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study) | Hepatology | 216 | 187 | |
1993 | An equilibrium model of drug utilization | KIN-WEI CHAN ; Walker A.M.; Yood R.A. | Journal of Clinical Epidemiology | 16 | 13 | |
2007 | Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings | Herrinton L.J.; Liu L.; Lafata J.E.; Allison J.E.; Andrade S.E.; Korner E.J.; KIN-WEI CHAN ; Platt R.; Hiatt D.; O'Connor S. | Inflammatory Bowel Diseases | 89 | 78 | |
2013 | Evaluating the safety of influenza vaccine using a claims-based health system | Kin-Wei Chan ; McCarthy, Natalie L.; Gee, Julianne; Lin, Nancy D.; Thyagarajan, Veena; Pan, Yi; Su, Sue; Turnbull, Bruce; Chan, K. Arnold; Weintraub, Eric | Vaccine | 13 | 13 | |
2009 | Evidence-based consensus development and reduction of rate of endoscopic thoracic sympathectomy: A national study | CHIA-HSUIN CHANG ; SHIH-HUNG YANG ; Hsieh B.-S.; KIN-WEI CHAN | Dermatologic Surgery | 0 | 0 | |
2004 | Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors | Kin-Wei Chan | Pharmacoepidemiology and Drug Safety | 18 | 15 | |
1998 | Factors related to delayed treatment and posttreatment symptom severity in Taiwanese patients with benign prostatic hyperplasia | CHIN-KUO CHANG ; HONG-JENG YU ; KIN-WEI CHAN ; WEI-CHU CHIE ; Chen J.; Chen Y.-T.; Lai M.-K. | Journal of the Formosan Medical Association | 0 | 0 | |
2006 | FDA drug prescribing warnings: Is the black box half empty or half full? | Kin-Wei Chan | Pharmacoepidemiology and Drug Safety | 69 | 67 | |
2006 | Frequency of high-risk use of QT-prolonging medications | Kin-Wei Chan | Pharmacoepidemiology and Drug Safety | 44 | 36 | |
2006 | Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients | Kin-Wei Chan | Annals of Pharmacotherapy | 14 | 11 | |